PETER GARCIA: Open Payments
NPI 1205832763 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,654 in 52 payments from 16 companies in 2025. Trend: 2023 $1,579 · 2024 $1,383 · 2025 $1,654
Food & beverage: $1,455Education: $199
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 14 | $317 |
| Sumitomo Pharma America, Inc. | 7 | $271 |
| Teleflex LLC | 2 | $202 |
| Astellas Pharma US Inc | 2 | $199 |
| ABBVIE INC. | 7 | $171 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $95 |
| PFIZER INC. | 3 | $73 |
| Endo USA, Inc. | 3 | $68 |
| Janssen Biotech, Inc. | 2 | $62 |
| Verity Pharmaceuticals Inc. | 2 | $57 |
Products named: XYOSTED, GEMTESA, UROLIFT, BOTOX, Nubeqa, XTANDI, ERLEADA, Tlando.
Industry payments across CA — which companies pay providers there.
